Clonal Evolution in Multiple Myeloma
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2016)
期刊
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
卷 16, 期 -, 页码 S130-S134出版社
CIG MEDIA GROUP, LP
关键词
作者
我是这篇论文的作者
推荐
Branching clonal evolution patterns predominate mutational landscape in multiple myeloma
Akanksha Farswan, Lingaraja Jena, Gurvinder Kaur, Anubha Gupta, Ritu Gupta, Lata Rani, Atul Sharma, Lalit Kumar
AMERICAN JOURNAL OF CANCER RESEARCH (2021)
Mutational landscape of chronic myelomonocytic leukemia in Chinese patients
Yanbo Nie, Liang Shao, Hong Zhang, Colin K. He, Hongyu Li, Junyan Zou, Long Chen, Huaiyue Ji, Hao Tan, Yani Lin, Kun Ru
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2022)
Compartment-specific mutational landscape of clonal hematopoiesis
Luise Hartmann, Judith S. Hecker, Maja Rothenberg-Thurley, Jennifer Riviere, Madlen Jentzsch, Bianka Ksienzyk, Michele C. Buck, Mark van der Garde, Luise Fischer, Susann Winter, Martina Rauner, Elena Tsourdi, Heike Weidner, Katja Sockel, Marie Schneider, Anne S. Kubasch, Martin Nolde, Dominikus Hausmann, Joerg Luetzner, Szymon Goralski, Florian Bassermann, Karsten Spiekermann, Lorenz C. Hofbauer, Sebastian Schwind, Uwe Platzbecker, Katharina S. Goetze, Klaus H. Metzeler
LEUKEMIA (2022)
Comprehensive characterization of the epigenetic landscape in Multiple Myeloma
Elina Alaterre, Sara Ovejero, Laurie Herviou, Hugues de Boussac, Giorgio Papadopoulos, Marta Kulis, Stephanie Boireau, Nicolas Robert, Guilhem Requirand, Angelique Bruyer, Guillaume Cartron, Laure Vincent, Anne Marie Martinez, Jose Ignacio Martin-Subero, Giacomo Cavalli, Jerome Moreaux
THERANOSTICS (2022)
Molecular and immunological mechanisms of clonal evolution in multiple myeloma
Stefan Forster, Ramin Radpour, Adrian F. Ochsenbein
FRONTIERS IN IMMUNOLOGY (2023)
Comprehensively Exploring the Mutational Landscape and Patterns of Genomic Evolution in Hypermutated Cancers
Peng-Chan Lin, Yu-Min Yeh, Hui-Ping Hsu, Ren-Hao Chan, Bo-Wen Lin, Po-Chuan Chen, Chien-Chang Pan, Keng-Fu Hsu, Jenn-Ren Hsiao, Yan-Shen Shan, Meng-Ru Shen
CANCERS (2021)
Tracking Clonal Evolution of Multiple Myeloma Using Targeted Next-Generation DNA Sequencing
Aleksander Salomon-Perzynski, Joanna Barankiewicz, Marcin Machnicki, Irena Misiewicz-Krzeminska, Michal Pawlak, Sylwia Radomska, Agnieszka Krzywdzinska, Aleksandra Bluszcz, Piotr Stawinski, Malgorzata Rydzanicz, Natalia Jakacka, Iwona Solarska, Katarzyna Borg, Zofia Spyra-Gorny, Tomasz Szpila, Bartosz Pula, Sebastian Grosicki, Tomasz Stoklosa, Rafal Ploski, Ewa Lech-Maranda, Jana Jakubikova, Krzysztof Jamroziak
BIOMEDICINES (2022)
Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications
Aleksander Salomon-Perzynski, Krzysztof Jamroziak, Eliza Glodkowska-Mrowka
DIAGNOSTICS (2021)
Malignant clonal evolution drives multiple myeloma cellular ecological diversity and microenvironment reprogramming
Yuanzheng Liang, Haiyan He, Weida Wang, Henan Wang, Shaowen Mo, Ruiying Fu, Xindi Liu, Qiong Song, Zhongjun Xia, Liang Wang
MOLECULAR CANCER (2022)
Somatic Mutational Landscape in Mexican Patients: CDH1 Mutations and chr20q13.33 Amplifications Are Associated with Diffuse-Type Gastric Adenocarcinoma
Dennis Cerrato-Izaguirre, Yolanda Chirino, Diddier Prada, Ericka Marel Quezada-Maldonado, Luis A. Herrera, Angelica Hernandez-Guerrero, Juan Octavio Alonso-Larraga, Roberto Herrera-Goepfert, Luis F. Onate-Ocana, David Cantu-de-Leon, Abelardo Meneses-Garcia, Patricia Basurto-Lozada, Carla Daniela Robles-Espinoza, Javier Camacho, Claudia M. Garcia-Cuellar, Yesennia Sanchez-Perez
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
The tumor mutational landscape of BRCA2-deficient primary and metastatic prostate cancer
Kevin H. Kensler, Shakuntala Baichoo, Shailja Pathania, Timothy R. Rebbeck
NPJ PRECISION ONCOLOGY (2022)
Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines
Mariaserena Giliberto, Leonardo Miranda Santana, Toril Holien, Kristine Misund, Sigve Nakken, Daniel Vodak, Eivind Hovig, Leonardo A. Meza-Zepeda, Eivind Coward, Anders Waage, Kjetil Tasken, Sigrid S. Skanland
FRONTIERS IN ONCOLOGY (2022)
The Mutational Landscape of SARS-CoV-2
Bryan Saldivar-Espinoza, Pol Garcia-Segura, Nil Novau-Ferre, Guillem Macip, Ruben Martinez, Pere Puigbo, Adria Cereto-Massague, Gerard Pujadas, Santiago Garcia-Vallve
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
The Role of Clonal Evolution on Progression, Blood Parameters, and Response to Therapy in Multiple Myeloma
Sarah Sandmann, Katharina Karsch, Peter Bartel, Rita Exeler, Tobias J. J. Brix, Elias K. K. Mai, Julian Varghese, Georg Lenz, Cyrus Khandanpour
FRONTIERS IN ONCOLOGY (2022)
Mutational Landscape and Precision Medicine in Hepatocellular Carcinoma
Leva Gorji, Zachary J. Brown, Timothy M. Pawlik
CANCERS (2023)
Carfilzomib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma: A Phase I Trial
Swetha Kambhampati, Bita Fakhri, Weiyun Z. Ai, Lawrence D. Kaplan, Joseph M. Tuscano, Matthew J. Wieduwilt, Akshay Sudhindra, Erika Cavallone, Jesika Reiner, Charlie Aoun, Miguel Castillo, Michelle Martinelli, Teresa Ta, Diem Le, Michelle Padilla, Erika Crawford, Charalambos B. Andreadis
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
B-Cell Lymphomas, Version 5.2021 Featured Updates to the NCCN Guidelines
Andrew D. Zelenetz, Leo I. Gordon, Julie E. Chang, Beth Christian, Jeremy S. Abramson, Ranjana H. Advani, Nancy L. Bartlett, L. Elizabeth Budde, Paolo F. Caimi, Sven De Vos, Bhagirathbhai Dholaria, Bita Fakhri, Luis E. Fayad, Martha J. Glenn, Thomas M. Habermann, Francisco Hernandez-Ilizaliturri, Eric Hsi, Boyu Hu, Mark S. Kaminski, Christopher R. Kelsey, Nadia Khan, Susan Krivacic, Ann S. LaCasce, Megan Lim, Mayur Narkhede, Rachel Rabinovitch, Praveen Ramakrishnan, Erin Reid, Kenneth B. Roberts, Hayder Saeed, Stephen D. Smith, Jakub Svoboda, Lode J. Swinnen, Joseph Tuscano, Julie M. Vose, Mary A. Dwyer, Hema Sundar
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotin
Tiffany Guan, Mimi Lo, Rebecca Young, Weiyun Ai, Fouad Boulbol, Hanson Mouanoutoua, Raymond Chu, Charalambos Andreadis, Lawrence Kaplan, Haifaa Abdulhaq, Bita Fakhri
LEUKEMIA & LYMPHOMA (2022)
Copy Number Loss at Chromosome 14q11.2 Correlates With the Proportion of T Cells in Biopsies and Helps Identify T-Cell Neoplasms
Arzu Saglam, Kunwar Singh, Jyoti Kumar, Sumanth Gollapudi, Soham Mukherjee, Amol Singh, Alexandra Butzmann, Lawrence Kaplan, Charambalos Andreadis, Weiyun Z. Ai, Bita Fakhri, Aleksander Rajkovic, Kwun Wah Wen, Courtney Onodera, Jessica Van Ziffle, Patrick W. Devine, Robert S. Ohgami
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2023)
Outcomes of Therapies and Resistance Mutations Following Non-Covalent Bruton's Tyrosine Kinase Inhibitor Treatment for Patients with Chronic Lymphocytic Leukemia and Richter Transformation
Meghan C. Thompson, Catherine C. Coombs, Lindsey E. Roeker, Jeffrey L. Jensen, Nirav N. Shah, Thomas Luo, Krish Patel, Neil Bailey, Bita Fakhri, Toby A. Eyre, Paola Ghione, Joanna M. Rhodes, Andrew D. Zelenetz, Justin Taylor, Maria Lia Palomba, Kendall Meyer, Danielle Rao, Yehudit Fox, Julia H. Aronson, Sarah Court, Omar Abdel-Wahab, Anthony R. Mato
BLOOD (2022)
SOHO State of the Art Updates and Next Questions: New Targetable Pathways in Chronic Lymphocytic Leukemia
Bita Fakhri, Alexey Danilov
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2023)
Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy
Rahul Banerjee, Victoria Wang, Chiung-Yu Huang, Divita Pandita, Michelle K. K. Leonard, Siobhan LaRue, Michael Ahmadi, Lawrence Kaplan, Weiyun Z. Z. Ai, Bita Fakhri, Michael Spinner, Madhav Rao Seshadri, Miguel Hernandez Pampaloni, Charalambos Babis Andreadis
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)
Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004) a multicentre, open-label, single-arm, phase 1-2 study & nbsp;
Tanya Siddiqi, David G. Maloney, Saad S. Kenderian, Danielle M. Brander, Kathleen Dorritie, Jacob Soumerai, Peter A. Riedell, Nirav N. Shah, Rajneesh Nath, Bita Fakhri, Deborah M. Stephens, Shuo Ma, Tatyana Feldman, Scott R. Solomon, Stephen J. Schuster, Serena K. Perna, Sherilyn A. Tuazon, San -San Ou, Eniko Papp, Leanne Peiser, Yizhe Chen, William G. Wierda
LANCET (2023)
Value of embedded palliative care: outpatient palliative care and health care utilization for patients with hematologic malignancies
Mazie Tsang, Kara Bischoff, Kelly L. Schoenbeck, Kim Berry, David O'Riordan, Bita Fakhri, Sandy W. Wong, Nina Shah, Rebecca Olin, Charalambos Andreadis, Jules Vieaux, Eve Cohen, Nancy Shepard Lopez, Gabriel N. Mannis, Michael Rabow
BLOOD ADVANCES (2023)
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia
Anthony R. Mato, Jennifer A. Woyach, Jennifer R. Brown, Paolo Ghia, Krish Patel, Toby A. Eyre, Talha Munir, Ewa Lech-Maranda, Nicole Lamanna, Constantine S. Tam, Nirav N. Shah, Catherine C. Coombs, Chaitra S. Ujjani, Bita Fakhri, Chan Y. Cheah, Manish R. Patel, Alvaro J. Alencar, Jonathon B. Cohen, James N. Gerson, Ian W. Flinn, Shuo Ma, Deepa Jagadeesh, Joanna M. Rhodes, Francisco Hernandez-Ilizaliturri, Pier L. Zinzani, John F. Seymour, Minna Balbas, Binoj Nair, Paolo Abada, Chunxiao Wang, Amy S. Ruppert, Denise Wang, Donald E. Tsai, William G. Wierda, Wojciech Jurczak
NEW ENGLAND JOURNAL OF MEDICINE (2023)
Pirtobrutinib, a Highly Selective, NonCovalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study
Jonathon B. Cohen, Nirav N. Shah, Alvaro J. Alencar, James N. Gerson, Manish R. Patel, Bita Fakhri, Wojciech Jurczak, Xuan Ni Tan, Katharine L. Lewis, Timothy Fenske, Catherine C. Coombs, Ian W. Flinn, David J. Lewis, Steven Le Gouill, M. Lia Palomba, Jennifer A. Woyach, John M. Pagel, Nicole Lamanna, Minal A. Barve, Paolo Ghia, Toby A. Eyre, Pier Luigi Zinzani, Chaitra S. Ujjani, Youngil Koh, Koji Izutsu, Ewa Lech-Maranda, Constantine S. Tam, Suchitra Sundaram, Ming Yin, Binoj Nair, Donald E. Tsai, Minna Balbas, Anthony R. Mato, Chan Y. Cheah, Michael L. Wang
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)
Pirtobrutinib, A Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated CLL/SLL: Updated Results from the Phase 1/2 BRUIN Study
Catherine C. Coombs, John M. Pagel, Nirav N. Shah, Nicole Lamanna, Talha Munir, Ewa Lech-Maranda, Toby A. Eyre, Jennifer A. Woyach, William G. Wierda, Chan Y. Cheah, Jonathon B. Cohen, Lindsey E. Roeker, Manish R. Patel, Bita Fakhri, Minal A. Barve, Constantine S. Tam, David Lewis, James N. Gerson, Alvaro Alencar, Chaitra Ujjani, Ian Flinn, Suchitra Sundaram, Shuo Ma, Deepa Jagadeesh, Joanna Rhodes, Justin Taylor, Omar Abdel-Wahab, Paolo Ghia, Stephen J. Schuster, Denise Wang, Binoj Nair, Edward Zhu, Donald E. Tsai, Matthew S. Davids, Jennifer R. Brown, Wojciech Jurczak, Anthony R. Mato
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2022)
Embedded outpatient palliative care for hematologic malignancies: Referral patterns and health care utilization.
Mazie Tsang, Kara E. Bischoff, Kelly L. Schoenbeck, Kim Berry, David O'Riordan, Bita Fakhri, Sandy Wai Kuan Wong, Nina Shah, Eve Cohen, Nancy Shepard Lopez, Gabriel N. Mannis, Michael W. Rabow
JOURNAL OF CLINICAL ONCOLOGY (2022)
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
Anthony R. Mato, Nirav N. Shah, Wojciech Jurczak, Chan Y. Cheah, John M. Pagel, Jennifer A. Woyach, Bita Fakhri, Toby A. Eyre, Nicole Lamanna, Manish R. Patel, Alvaro Alencar, Ewa Lech-Maranda, William G. Wierda, Catherine C. Coombs, James N. Gerson, Paolo Ghia, Steven Le Gouill, David John Lewis, Suchitra Sundaram, Jonathon B. Cohen, Ian W. Flinn, Constantine S. Tam, Minal A. Barve, Bryone Kuss, Justin Taylor, Omar Abdel-Wahab, Stephen J. Schuster, M. Lia Palomba, Katharine L. Lewis, Lindsey E. Roeker, Matthew S. Davids, Xuan Ni Tan, Timothy S. Fenske, Johan Wallin, Donald E. Tsai, Nora C. Ku, Edward Zhu, Jessica Chen, Ming Yin, Binoj Nair, Kevin Ebata, Narasimha Marella, Jennifer R. Brown, Michael Wang
LANCET (2021)
The role of acalabrutinib in adults with chronic lymphocytic leukemia
Bita Fakhri, Charalambos Andreadis
THERAPEUTIC ADVANCES IN HEMATOLOGY (2021)